According to Scholar Rock Holding's latest financial reports the company has a price-to-book ratio of 5.07.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 6.02 | 235.19% |
2022-12-31 | 1.80 | -64.55% |
2021-12-31 | 5.07 | -20.26% |
2020-12-31 | 6.36 | 82.74% |
2019-12-31 | 3.48 | -38.42% |
2018-12-31 | 5.65 | |
2017-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Organovo ONVO | 1.97 | -61.13% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 4.74 | -6.62% | ๐ฌ๐ง UK |
Novavax NVAX | -0.8453 | -116.67% | ๐บ๐ธ USA |
Novocure
NVCR | 3.63 | -28.36% | Jersey |